Pfizer (NYSE: PFE) and Ranbaxy Labs of India are coming under some heat regarding generic versions of Lipitor.

According ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE